IRIS Institutional Research Information System - OPENBS Open Archive UniBS

INCIARDI, RICCARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.977
AS - Asia 1.918
EU - Europa 1.021
SA - Sud America 452
AF - Africa 51
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.427
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.891
SG - Singapore 726
CN - Cina 479
BR - Brasile 376
HK - Hong Kong 258
DE - Germania 197
VN - Vietnam 167
IT - Italia 151
FI - Finlandia 110
FR - Francia 102
GB - Regno Unito 98
RU - Federazione Russa 85
IE - Irlanda 78
TR - Turchia 77
IN - India 60
UA - Ucraina 49
CA - Canada 45
BD - Bangladesh 39
MX - Messico 28
AR - Argentina 24
PL - Polonia 23
SE - Svezia 22
CZ - Repubblica Ceca 21
ZA - Sudafrica 20
IQ - Iraq 16
JP - Giappone 15
ES - Italia 14
ID - Indonesia 13
SA - Arabia Saudita 12
AT - Austria 11
BE - Belgio 11
NL - Olanda 11
PK - Pakistan 11
VE - Venezuela 10
EC - Ecuador 9
CL - Cile 8
CO - Colombia 8
MA - Marocco 8
PY - Paraguay 8
BG - Bulgaria 7
JO - Giordania 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
LT - Lituania 6
KE - Kenya 5
KZ - Kazakistan 5
LV - Lettonia 5
BO - Bolivia 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
EG - Egitto 4
ET - Etiopia 4
IL - Israele 4
UZ - Uzbekistan 4
TN - Tunisia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
CI - Costa d'Avorio 2
CY - Cipro 2
HU - Ungheria 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MD - Moldavia 2
MK - Macedonia 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
PS - Palestinian Territory 2
PT - Portogallo 2
SC - Seychelles 2
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CG - Congo 1
DZ - Algeria 1
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
IR - Iran 1
LK - Sri Lanka 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
RS - Serbia 1
SV - El Salvador 1
TW - Taiwan 1
Totale 6.427
Salva come PNG Salva come JPEG
Città #
Singapore 355
Ashburn 319
Hong Kong 256
San Jose 220
Fairfield 196
The Dalles 154
Beijing 141
New York 132
Chandler 127
Princeton 126
Woodbridge 95
Los Angeles 93
Helsinki 90
Houston 85
Wilmington 80
Seattle 78
Lauterbourg 73
Cambridge 72
Dublin 72
Munich 69
Dallas 64
Istanbul 64
Ho Chi Minh City 54
Jacksonville 46
São Paulo 44
Ann Arbor 39
Council Bluffs 39
Hanoi 37
Moscow 35
San Francisco 35
London 31
Buffalo 30
Frankfurt am Main 29
Redondo Beach 29
Milan 28
Brescia 27
San Diego 26
Orem 25
Shanghai 24
Chicago 23
Des Moines 22
Montreal 21
Brno 19
Chennai 19
Warsaw 19
Santa Clara 16
Tokyo 14
Atlanta 12
Düsseldorf 12
Nuremberg 12
Romola 12
Toronto 12
Boston 11
Brussels 11
Johannesburg 11
Washington 11
Brooklyn 10
Denver 10
Guangzhou 10
Querétaro 10
Rome 10
Da Nang 9
Tianjin 9
Turku 9
Belo Horizonte 8
Haiphong 8
Lappeenranta 8
Phoenix 8
Poplar 8
Pune 8
Guarulhos 7
Mexico City 7
Mumbai 7
Porto Alegre 7
Stockholm 7
Amman 6
Brasília 6
Manchester 6
Menlo Park 6
Paris 6
Rio de Janeiro 6
Verona 6
Amsterdam 5
Cleveland 5
Dhaka 5
Florianópolis 5
Fortaleza 5
Guayaquil 5
Kyiv 5
Padova 5
Portsmouth 5
Riga 5
São José dos Campos 5
Addis Ababa 4
Buenos Aires 4
Bắc Ninh 4
Cape Town 4
City of London 4
Curitiba 4
Erbil 4
Totale 4.081
Salva come PNG Salva come JPEG
Nome #
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 201
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy 187
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 173
Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study 135
Diagnosing pneumothorax through standardized bilateral ultrasound images comparison 122
Coronavirus 2019 Disease (COVID-19), Systemic Inflammation, and Cardiovascular Disease 121
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) 120
Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features 118
The prognostic value of serial troponin measurements in patients admitted for COVID-19 116
Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry 114
Adherence and optimization of angiotensin converting enzyme inhibitor/angiotensin II receptors blockers and beta-blockers in patients hospitalized for acute heart failure 111
COVID 19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease 109
Implications for the Care of Patients with COVID-19 and Inflammatory Myocardial Disease-Reply 109
ACE2 down-regulation may contribute to the increased thrombotic risk in COVID-19 107
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 106
Changes in Right Ventricular-to-Pulmonary Artery Coupling After Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation 106
Atrial fibrillation in the COVID-19 era: Simple bystander or marker of increased risk? 103
Cardiac biomarkers and mortality in COVID-19 infection: A review 101
Congestion in Patients with Advanced Heart Failure: Assessment and Treatment 101
Combined Role of Troponin and Natriuretic Peptides Measurements in Patients With Covid-19 (from the Cardio-COVID-Italy Multicenter Study) 101
Standardizing Bilateral Ultrasound Images Comparison for the Diagnosis of Pneumothorax: A Pilot Study 100
Early Small Creatinine Shift Predicts Contrast-Induced Acute Kidney Injury and Persistent Renal Damage after Percutaneous Coronary Procedures: Early creatinine shift predicts CI-AKI 98
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study 97
Endothelial dysfunction in COVID-19 patients assessed with Endo-PAT2000 96
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world 93
Cardiac Mechanics Assessment and the Risk of Heart Failure in the General Population 93
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study 92
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study 90
Association of Echocardiographic Measures of Left Atrial Function and Size With Incident Dementia 89
Prognostic significance of serum potassium in patients hospitalized for acute heart failure 87
Vericiguat for Heart Failure with Reduced Ejection Fraction 87
Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study 87
Cardiovascular imaging in arrhythmogenic right ventricular dysplasia/cardiomyopathy 84
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 83
Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure 83
Anatomical features and clinical correlations in Caucasian patients with definite arrhythmogenic right ventricular dysplasia/cardiomyopathy 83
Atrial Fibrillation and Ischemic Stroke with the Amyloidogenic V122I Transthyretin Variant among Black Americans 83
Association of Left Atrial Structure and Function With Heart Failure in Older Adults 79
Combined pre- and post-capillary pulmonary hypertension in left heart disease 78
Impact of COVID-2019 outbreak on prevalence, clinical presentation and outcomes of ST-elevation myocardial infarction 77
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 77
Left atrial structure and function and the risk of death or heart failure in atrial fibrillation 76
Mitral regurgitation, edge-to-edge valve repair and the left atrium: one step beyond the left ventricle? 74
Chemotherapy cardiotoxicity: Cardioprotective drugs and early identification of cardiac dysfunction 72
Association of Physical Activity With Left Atrial Function in Older Adults: The ARIC Study 71
Cardiac Structure and Function and Diabetes‐Related Risk of Death or Heart Failure in Older Adults 71
Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure 70
Right cardiac chambers' involvement as the first manifestation of recurrent complex karyotype acute myeloid leukemia 70
Prognostic effects of rosuvastatin in patients with co-existing chronic obstructive pulmonary disease and chronic heart failure: A sub-analysis of GISSI-HF trial 70
Mitral regurgitation, left atrial structural and functional remodelling and the effect on pulmonary haemodynamics 69
Usefulness of strain imaging echocardiography in arrhythmogenic right ventricular cardiomyopathy: clinical perspective 69
Determinants of exercise intolerance symptoms considered non-specific for heart failure in patients with stage A and B: role of the left atrium in the transition phase to overt heart failure 69
Multimodality imaging in the diagnostic management of concomitant aortic stenosis and transthyretin-related wild-type cardiac amyloidosis 67
Fill in the Gaps of Secondary Mitral Regurgitation: a Continuum Challenge From Pathophysiology to Prognosis 67
Left Atrial Structure and Function of the Amyloidogenic V122I Transthyretin Variant in Elderly African Americans 67
Left atrial disease and left atrial reverse remodelling across different stages of heart failure development and progression: a new target for prevention and treatment 66
Criteria for Iron Deficiency in Patients With Heart Failure 66
Echocardiographic advances in hypertrophic cardiomyopathy: Three-dimensional and strain imaging echocardiography 65
Left Atrial Mechanical Dysfunction and the Risk for Ischemic Stroke in People Without Prevalent Atrial Fibrillation or Stroke : A Prospective Cohort Study 64
How to incorporate left atrial strain in the diagnostic algorithm of left ventricular diastolic dysfunction 64
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry 63
Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry 62
Prognostic Benefit of New Drugs for HFrEF: A Systematic Review and Network Meta-Analysis 59
Mitral regurgitation and dyspnoea: the expanding role of mitral effective regurgitant orifice among un-selected patients 58
Therapeutic management in Sicilian patients with definite arrhythmogenic right ventricular dysplasia/cardiomyopathy and focus on the role of implantable cardioverter-defibrillator therapy 58
Left atrial structural and mechanical remodelling in heart failure with reduced ejection fraction 56
Left atrium: A forgotten biomarker and a potential target in cardiovascular medicine 56
Prognostic Value of Minimal Left Atrial Volume in Heart Failure With Preserved Ejection Fraction 54
Differences in Left Atrial Size and Function and Supraventricular Ectopy Between Black and White Participants in the ARIC Study 53
Long COVID-19: A Tangled Web of Lungs, Heart, Mind, and Gender 50
Identification and quantification of congestion in heart failure: a work in progress 49
Treatment decision making in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: State of the art 49
Collagen homeostasis of the left atrium: an emerging treatment target to prevent heart failure? 49
Epicardial adipose tissue in heart failure: risk factor or mediator? 45
Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction 40
Type of hospitalisations and in-hospital outcomes in the Italian coronary care unit network at the time of COVID-19 pandemic: the BLITZ-COVID19 Registry 40
Reply to "Clinical implications of left atrial changes after optimization of medical therapy in heart failure patients" 40
Implantation of a biventricular defibrillator in a borderline case of arrhythmogenic right ventricular dysplasia/cardiomyopathy 39
Totale 6.524
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.533
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.533
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116 0 0 0 0 0 0 0 0 0 0 0 16
2021/2022498 51 32 17 17 38 21 22 26 51 48 42 133
2022/2023475 81 33 11 13 24 126 1 39 77 1 38 31
2023/2024663 29 6 68 52 45 137 26 17 158 8 12 105
2024/20251.336 12 22 20 187 89 124 149 51 125 112 273 172
2025/20262.841 283 358 239 459 298 176 397 109 180 239 101 2
Totale 6.524